MondayFeb 14, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Seeks EUA to Test Cannabis Product Against COVID Virus, Building on Early Study Results as it Names New Chief Strategy Officer

Recent research efforts have targeted the potential of cannabis compounds to combat COVID-19 infection as the worldwide pandemic presses forward into its third year Perhaps most notable among the early-stage research efforts is a study by Oregon State University that found high doses of two specific cannabinoids bound to spike proteins such as COVID’S SARS-CoV-2 and inhibited their potential for infection Cannabis cultivator and brand builder Flora Growth Corp. has filed a provisional patent application for a cannabinoid-based formula that it is simultaneously seeking approval from Colombia’s food and drug regulatory authority for a study and potential clinical trial in…

Continue Reading

MondayFeb 14, 2022 9:30 am

Nemaura Medical Inc.’s (NASDAQ: NMRD) CEO Dr. Faz Chowdhury Addresses Growing CGM Demand at H.C. Wainwright BioConnect Conference

NMRD CEO Dr. Faz Chowdhury presented at H.C. Wainwright BioConnect Conference held January 10-13, 2022 Presentation revealed growing need for CGM devices, diabetes market estimated at $150 billion NMRD's sugarBEAT(R) devices measure glucose at the skin surface, non-invasive, easy to use NMRD recently commenced product shipments in lieu of an order for 5,000 CGM devices and 200,000 sensors to UK licensing partner MySugarWatch Limited NMRD recently announced launch of Miboko metabolic health program targeted at global employers and insurers Dr. Faz Chowdhury, CEO of Nemaura Medical (NASDAQ: NMRD), recently presented at the H.C. Wainwright BioConnect Conference on January 10-13, 2022,…

Continue Reading

MondayFeb 14, 2022 9:15 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives IRB Approval for Kernel Flow Feasibility Study

Institution Review Board gives green light to study designed around Kernel’s quantitative neuroimaging technology Kernel Flow device provides ability to measure longitudinal brain activity before, during and after a psychedelic experience CYBN CEO says results from study will further support company’s mission to develop psychedelics into therapeutics Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has received approval to move forward on a key feasibility study designed to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics (https://ibn.fm/f0HXk). The approval, granted by the Institution Review Board (“IRB”), gives a green light to a Cybin-sponsored study…

Continue Reading

MondayFeb 14, 2022 9:00 am

Physics, Cost, Favor FuelPositive Corp.’s (TSX.V: NHHH) (OTCQB: NHHHF) Vision of Using Green Ammonia as a Vector for Hydrogen; Company Provides Corporate Update

Ammonia is less expensive to transport long-distance via seaborne vessels than liquid hydrogen Ammonia has a lower boil-off rate and higher volumetric energy density than liquid hydrogen; additionally, an ammonia carrier requires less capital investment than a liquid hydrogen transportation vessel FuelPositive holds that green ammonia is a perfect substitute for transporting and storing hydrogen because of existing infrastructure The company recently provided a corporate update in which it detailed the progress of the building of the first demonstration systems for its green ammonia production technology While the hydrogen economy envisions a decarbonized future where green hydrogen is used to…

Continue Reading

FridayFeb 11, 2022 2:24 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Attentive as Broad Federal Cannabis Decriminalization Agenda Gets off the Ground

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is closely watching the growing bipartisan support for federal cannabis reform. A recent article, which contains excerpts from a December 2021 write-up in the National Law Review (“NLR”), reads, “‘Long-anticipated federal cannabis reform may be on the horizon… In the last month, bipartisan governors and groups from both bodies of Congress have established support for cannabis policies that would reshape federal enforcement and set the stage for further state legalization.’ The article specifically noted the States Reform Act, which was introduced by South Carolina Representative Nancy Mace in November;…

Continue Reading

FridayFeb 11, 2022 1:09 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) to Be Evaluated for Potential Treatment Options for Multiple Conditions

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Chris Bunka noted that Lexaria would continue to see significant milestones in utilizing its patented DehydraTECH drug delivery technology in 2022. “Calendar 2022 will continue to see significant milestones utilizing DehydraTECH-CBD for investigation of heart disease and hypertension; and separately, for oral nicotine delivery as an alternative to smoking… We are delighted to announce that DehydraTECH as an enhanced drug delivery platform will also be evaluated for characteristics and potential treatment options for hormone replacement, dementia, rheumatoid disease and diabetes,” a recent article quotes Bunka as saying. Lexaria received independent review board approval, marking…

Continue Reading

FridayFeb 11, 2022 12:36 pm

QualityStocksNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Appoints New COO in Readiness for Manufacturing and Distribution Scale-Up, Commercialization Phase of Growth

Nemaura Medical (NASDAQ: NMRD) recently appointed Dr. Arash Ghadar as its chief operating officer. Dr. Ghadar brings decades of health care and technical experience to Nemaura, including from his previous role as technical director at Datalink Electronics and his current director role at Medilink Midlands. “Ash will play an important role at Nemaura as we begin to scale up our manufacturing and distribution operations… He brings over 20 years of product development, management and leadership experience spanning both business and technical disciplines. His main area of expertise is in the medical devices sector, and primarily within a contract design and…

Continue Reading

FridayFeb 11, 2022 12:22 pm

QualityStocksNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Greenlit to Proceed with Mechanized Drilling, Ground Geophysical Surveys at Flagship RLX Property

StraightUp Resources (CSE: ST) (OTCQB: STUPF) expects to proceed in its 2022 work programs for its flagship property, a 10,000-hectare tract of land located in the Red Lake District that has shown great promise in gold mining. The work programs include drilling the most prospective targets in the summer. This follows receipt of its early exploration permit (“PR-21-000261”) for the eastern block of its RLX North Property from the Ministry of Northern Development and Mine, Natural Resources and Forestry (“NDMNF”). A recent article reads: “The permit allows StraightUp to proceed with mechanized drilling along with ground geophysical surveys that require…

Continue Reading

FridayFeb 11, 2022 12:10 pm

QualityStocksNewsBreaks – PlantX Life Inc.’s (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) ‘Medically Speaking’ Providing Evidence-Based Information, Offering Creative Solutions

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) recently launched a new YouTube series, ‘Medically Speaking,’ intended to promote education and offer consumers the necessary resources to help them attain their plant-based objectives. The episodes will focus the conversation around high-impact and novel topics, discussing how plant-based lifestyles can improve health and wellbeing. As part of the series, host Adam Kruger will engage guests drawn from PlantX’s Medical Advisory Board, with the first season featuring experienced health care professionals with a passion for promoting plant-based living and wellness. A recent article reads, “Beyond providing evidence-based information to clarify potential…

Continue Reading

FridayFeb 11, 2022 11:50 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Creates ‘The Real Deal’ for Artists, Exciting Community for Fans with Artist Republik, Fan Pass Synergies

Friendable (OTC: FDBL), a mobile technology and marketing company, recently released more details surrounding the acquisition of Artist Republik, a reputable music distribution company, and how it impacts the Fan Pass Live artist streaming platform. According to CEO and Co-Founder Robert A. Rositano, Artist Republik has experienced great momentum in music distribution, and, following the acquisition, Friendable and Fan Pass are beneficiaries of approximately 100,00 artists alongside revenues that exceeded $450,000 in approximately eight months of 2021. “The offering provided by Artist Republik is much like what a manager and label would offer a recording artist, but without the excessive…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered